NCT05931029View on ClinicalTrials.gov

Study of the Therapeutic Effects of Naohuan Dan and Idebenone in Treating Mild Cognitive Impairment With Kidney Deficiency and Phlegm Stasis

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Mild Cognitive Impairment
Interventions
DRUG

Idebenone

The control group took Idebenone orally for 12 weeks.

DRUG

Naohuan Dan and Idebenone

The treatment group took Naohuan Dan combined with Idebenone for treatment. Naohuan Dan is a granular preparation taken once a day, while Idebenone is a tablet taken three times a day for a total of 12 weeks.

Trial Locations (1)

510220

Sun Yat-sen Memorial Hospital，Sun Yat-sen University，Guangzhou 510300，China, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT05931029 - Study of the Therapeutic Effects of Naohuan Dan and Idebenone in Treating Mild Cognitive Impairment With Kidney Deficiency and Phlegm Stasis | Biotech Hunter | Biotech Hunter